GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » CardioGenics Holdings Inc (OTCPK:CGNH) » Definitions » Cyclically Adjusted PS Ratio

CardioGenics Holdings (CardioGenics Holdings) Cyclically Adjusted PS Ratio : (As of Jun. 08, 2024)


View and export this data going back to 2004. Start your Free Trial

What is CardioGenics Holdings Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


CardioGenics Holdings Cyclically Adjusted PS Ratio Historical Data

The historical data trend for CardioGenics Holdings's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CardioGenics Holdings Cyclically Adjusted PS Ratio Chart

CardioGenics Holdings Annual Data
Trend Jul06 Jul07 Jul08 Oct09 Oct10 Oct11 Oct12 Oct13 Oct14 Oct15
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

CardioGenics Holdings Quarterly Data
Apr11 Jul11 Oct11 Jan12 Apr12 Jul12 Oct12 Jan13 Apr13 Jul13 Oct13 Jan14 Apr14 Jul14 Oct14 Jan15 Apr15 Jul15 Oct15 Jan16
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of CardioGenics Holdings's Cyclically Adjusted PS Ratio

For the Diagnostics & Research subindustry, CardioGenics Holdings's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CardioGenics Holdings's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, CardioGenics Holdings's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where CardioGenics Holdings's Cyclically Adjusted PS Ratio falls into.



CardioGenics Holdings Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

CardioGenics Holdings's Cyclically Adjusted Revenue per Share for the quarter that ended in Jan. 2016 is calculated as:

For example, CardioGenics Holdings's adjusted Revenue per Share data for the three months ended in Jan. 2016 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jan. 2016 (Change)*Current CPI (Jan. 2016)
=0/100.1844*100.1844
=0.000

Current CPI (Jan. 2016) = 100.1844.

CardioGenics Holdings Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
200604 0.014 86.279 0.016
200607 0.005 86.595 0.006
200610 0.010 86.121 0.012
200701 0.012 86.437 0.014
200704 0.013 88.175 0.015
200707 0.008 88.491 0.009
200710 0.006 88.175 0.007
200801 0.008 88.333 0.009
200804 0.007 89.676 0.008
200807 0.009 91.493 0.010
200810 0.007 90.466 0.008
200901 0.007 89.281 0.008
200904 0.005 89.992 0.006
200907 0.000 90.624 0.000
200910 0.000 90.545 0.000
201001 0.000 90.940 0.000
201004 0.000 91.651 0.000
201007 0.000 92.283 0.000
201010 0.000 92.757 0.000
201101 0.000 93.074 0.000
201104 0.000 94.654 0.000
201107 0.000 94.812 0.000
201110 0.000 95.444 0.000
201201 0.000 95.365 0.000
201204 0.000 96.550 0.000
201207 0.000 95.997 0.000
201210 0.000 96.550 0.000
201301 0.000 95.839 0.000
201304 0.000 96.945 0.000
201307 0.000 97.261 0.000
201310 0.000 97.182 0.000
201401 0.000 97.261 0.000
201404 0.000 98.920 0.000
201407 0.000 99.315 0.000
201410 0.000 99.473 0.000
201501 0.000 98.209 0.000
201504 0.000 99.710 0.000
201507 0.000 100.579 0.000
201510 0.000 100.500 0.000
201601 0.000 100.184 0.000

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


CardioGenics Holdings  (OTCPK:CGNH) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


CardioGenics Holdings Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of CardioGenics Holdings's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


CardioGenics Holdings (CardioGenics Holdings) Business Description

Traded in Other Exchanges
N/A
Address
6295 Northam Drive, Unit 8, Mississauga, ON, CAN, L4V 1W8
CardioGenics Holdings Inc is a biotechnology company. It is engaged in the development and commercialization of diagnostic test products for the In-Vitro Diagnostics (IVD) testing market. The company's objective is to create, develop and commercialize superior, innovative, cost-effective and patent-protected products for the IVD based on proprietary technologies. Its products include QL Care Analyzer, Immunoassay Tests, and Paramagnetic Beads. The business activity is primarily carried out through the region of Canada.

CardioGenics Holdings (CardioGenics Holdings) Headlines

No Headlines